Avenue Therapeutics Inc (ATXI) stock is down -55.17% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives ATXI stock a score of 34 out of a possible 100.
That rank is mainly influenced by a long-term technical score of 2. ATXI's rank also includes a short-term technical score of 3. The fundamental score for ATXI is 98. In addition to the average rating from Wall Street analysts, ATXI stock has a mean target price of 9. This means analysts expect the stock to gain 105.48% over the next 12 months.
What's Happening with ATXI Stock Today
Avenue Therapeutics Inc (ATXI) stock is higher by 3.55% while the S&P 500 is higher by 0.75% as of 10:43 AM on Friday, May 7. ATXI is higher by $0.15 from the previous closing price of $4.23 on volume of 69,010 shares. Over the past year the S&P 500 is higher by 46.92% while ATXI is down -55.17%. ATXI lost -$0.31 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Avenue Therapeutics Inc (ATXI) Stock.